Archive for July, 2008

More brain disease reported by Biogen Idec

July 31, 2008 at 10:03 pm · Filed under Uncategorized

Biogen Idec Inc. of Cambridge, Mass., along with Elan Corp., reported to regulators two more cases of the potentially fatal brain infection PML among patients taking their multiple sclerosis drug Tysabri, the companies said Thursday.

Comments off

Depomed posts $3.5M Q2 profit on litigation payment

July 31, 2008 at 8:32 pm · Filed under Uncategorized

Depomed Inc. reported net income of $3.5 million, or 7 cents a share for the second quarter, compared to a loss in the same period last year of $9 million, or 20 cents a share. (DEPO)

Comments off

USF receives $128 million award for diabetes research

July 31, 2008 at 6:57 pm · Filed under Uncategorized

The National Institutes of Health awarded $128 million to a University of South Florida research team conducting worldwide studies on the prevention and treatment of juvenile diabetes. Jeffrey Krischer is leading the USF research team.

Comments off

Gilead adds Alabama professor to board

July 31, 2008 at 5:12 pm · Filed under Uncategorized

HIV drug maker Gilead Sciences Inc. added Richard Whitley, M.D., a University of Alabama professor, to its board of directors. (GILD)

Comments off

Ore Pharmaceuticals buys new drug for testing

July 31, 2008 at 4:42 pm · Filed under Uncategorized

Ore Pharmaceuticals Inc. has acquired a drug compound from Roche that it plans to take as its second candidate into clinical trials. (ORXE)

Comments off

« Previous entries ·